KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Non Operating Income (2017 - 2025)

Historic Non Operating Income for Ionis Pharmaceuticals (IONS) over the last 9 years, with Q3 2025 value amounting to $363000.0.

  • Ionis Pharmaceuticals' Non Operating Income rose 15563.38% to $363000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 1288.52%. This contributed to the annual value of $1.3 million for FY2024, which is 9057.94% down from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Non Operating Income stood at $363000.0, which was up 15563.38% from $102000.0 recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Non Operating Income registered a high of $11.2 million during Q2 2023, and its lowest value of -$12.3 million during Q2 2022.
  • In the last 5 years, Ionis Pharmaceuticals' Non Operating Income had a median value of $277000.0 in 2024 and averaged $1315.8.
  • Its Non Operating Income has fluctuated over the past 5 years, first tumbled by 581677.85% in 2021, then skyrocketed by 613333.33% in 2022.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Non Operating Income stood at -$477000.0 in 2021, then surged by 236.06% to $649000.0 in 2022, then plummeted by 38.52% to $399000.0 in 2023, then decreased by 21.3% to $314000.0 in 2024, then rose by 15.61% to $363000.0 in 2025.
  • Its last three reported values are $363000.0 in Q3 2025, $102000.0 for Q2 2025, and $465000.0 during Q1 2025.